812.21 HMGLPTHLATER

CH

Art. 32 Loi fédérale du 15 décembre 2000 sur les médicaments et les dispositifs médicaux (LPTh) - Publicité illicite

LPTh; Chapitre 2 Médicaments

Ouvrir la source officielle Texte complet (141 Articles) Version Markdown lisible par machine (.md)

Art. 32 LPTh · Publicité illicite

Est illicite: a. la publicité trompeuse ou contraire à l’ordre public et aux bonnes mœurs; b. la publicité pouvant inciter à un usage excessif, abusif ou inapproprié de médicaments; c. la publicité pour les médicaments qui ne peuvent être mis sur le marché ni à l’échelle nationale ni à l’échelle cantonale.

Est illicite la publicité destinée au public pour les médicaments: a. qui ne peuvent être remis que sur ordonnance; b. qui contiennent des stupéfiants ou des substances psychotropes visés par la loi du 3 octobre 1951 sur les stupéfiants ; c. qui, du fait de leur composition et de l’usage auquel ils sont destinés, ne peuvent être utilisés pour le diagnostic, la prescription ni le traitement correspondant sans l’intervention d’un médecin; d. qui font fréquemment l’objet d’un usage abusif ou qui peuvent engendrer une accoutumance ou une dépendance.

← Art. 31 LPTh Loi fédérale du 15 décembre 2000 sur les médicaments et les dispositifs médicaux (LPTh) - But Art. 33 LPTh →

Décisions judiciaires appliquant cette disposition (22)

VWBES.2004.60 · so (Art. 32 Abs. 2 lit. a HMG)

Apothecary's Hormone Ointment: Market Authorization vs. Magistral Preparation

This provision was cited by the court to justify that advertising an item as a prescription drug is impermissible.

C-3035/2022 (Art. 32 Abs. 2 Bst. a HMG)

Company fined for illegal advertising of migraine medication.

This provision prohibits public advertising for prescription-only medicines, which was the primary basis for deeming the article impermissible advertising.

C-1080/2022 (Art. 32 Abs. 2 Bst. a HMG)

Company Brochure's Detailed Drug Information Deemed Impermissible Public Advertising

This provision establishes that advertising for prescription-only medicines is prohibited, forming the legal basis for the finding that the brochure's content constituted unlawful public advertising.

C-2987/2021 (Art. 32 Abs. 1 Bst. a und b HMG)

Magazine's Pharmaceutical Advertising Violated Regulations

These provisions were applied to find that the article constituted inadmissible advertising due to being unbalanced, incomplete, and unobjective.

C-2987/2021 (Art. 32 Abs. 2 Bst. a HMG)

Magazine's Pharmaceutical Advertising Violated Regulations

This provision was applied to find that the article violated the prohibition of public advertising for prescription-only medicines.

C-2798/2020 (Art. 32 Abs. 1 Bst. a und b HMG)

Swissmedic vs. "Alcohol-free" and "Nature's Healing Powers" Claims

Basis for prohibiting misleading advertising and advertising that could lead to excessive or inappropriate use of medicines.

C-5490/2015 (Art. 32 Abs. 1 Bst. a HMG)

Pharmaceutical Advertising Violations: Misleading Pregnancy Claims

This provision prohibits misleading advertising, and was violated by the advertising claims found to be misleading.

C-5490/2015 (Art. 32 Abs. 1 Bst. b HMG)

Pharmaceutical Advertising Violations: Misleading Pregnancy Claims

This provision prohibits advertising that could lead to excessive, abusive, or inappropriate use of medicines, and was violated as the advertising claims could lead to such use.

C-3090/2014 (Art. 32 Abs. 1 Bst. c HMG)

Pharma Co. v. Advertising Regulations (Tick Repellent & Unapproved Drugs)

Used to prohibit the advertising of medicines that are not permitted to be placed on the market in Switzerland.

C-5023/2013 (Art. 32 Abs. 1 Bst. b HMG)

Federal Administrative Court upholds advertising restrictions on apothecary's products, but overturns moot prohibition on unapproved content.

Cited as a basis for prohibiting the use of the term 'Bestseller' in advertising for medicinal products, as it could lead to excessive, abusive, or inappropriate use.

C-5023/2013 (Art. 32 Abs. 1 Bst. c HMG)

Federal Administrative Court upholds advertising restrictions on apothecary's products, but overturns moot prohibition on unapproved content.

Implicitly used to justify the prohibition of advertising for medicinal products that are not approved in Switzerland.

C-546/2010 (Art. 32 Abs. 2 Bst. a HMG)

Swissmedic v. Aesthetics Company: Advertising Ban and Website Modifications

Cited as the legal basis for prohibiting public advertising of prescription-only medicines.

C-1795/2009 (Art. 32 Abs. 2 Bst. a HMG)

Regulatory Order on Botox and Vistabel Advertising Partially Overturned

This provision prohibits public advertising for prescription-only medicines, which was the basis for the court's decision regarding the advertising of Botox and Vistabel.

C-3441/2007 (Art. 32 Abs. 2 Bst. a HMG)

Pharmaceutical Company Website Access Restrictions

Prohibits public advertising for prescription-only medicines.

C-4173/2007 (Art. 32 Abs. 2 Bst. a HMG)

Online Prescription Drug Advertising: Password Protection Required

Cited as the prohibition against public advertising for prescription-only medicines, which forms the core issue of the case.